Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Renal Denervation in Patients With Uncontrolled Stage 2 Hypertension

NCT05372679 is registered in ClinicalTrials.gov with SoniVie Inc. as lead sponsor.

NCT NCT05372679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05372679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUS™) System for Renal Denervation in Patients With Uncontrolled Stage 2 Hypertension
Lead sponsor
SoniVie Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 11, 2022
Completion date
December 31, 2027
Enrollment
25 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled stage 2 hypertension